Campbell & CO Investment Adviser LLC Sarepta Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $808,609 - $1.17 Million	7,135 New	7,135 $1.13 Million
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $299,798 - $555,681	4,454 New	4,454 $429,000
Q1 2023 May 11, 2023	SELL	$117.53 - $155.99 $184,757 - $245,216	-1,572 Reduced 25.73%	4,537 $625,000
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $401,120 - $525,481	3,977 Added 186.54%	6,109 $791,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $161,413 - $254,219	2,132 New	2,132 $236,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $192,434 - $269,764	-2,917 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $202,381 - $253,049	2,917 New	2,917 $227,000
Q4 2019 Jan 23, 2020	SELL	$76.53 - $135.58 $512,980 - $908,792	-6,703 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$72.81 - $156.91 $488,045 - $1.05 Million	6,703 New	6,703 $505,000
Q3 2018 Nov 08, 2018	SELL	$115.31 - $161.51 $277,781 - $389,077	-2,409 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$71.74 - $153.69 $215,219 - $461,070	-3,000 Reduced 55.46%	2,409 $318,000
Q1 2018 May 04, 2018	BUY	$54.02 - $82.27 $292,194 - $444,998	5,409 New	5,409 $401,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.